Adrenal cortex autotransplantation with ACTH stimulation may be an alternative therapy for patients with bilateral adrenalectomy to avoid adrenal crisis, but its underlying mechanism has not been elucidated. Previously, we detected Dhh upregulation in rat adrenocortical autografts after transplantation. Here, we investigated potential regulators such as Gata4, Gata6, Sry and Sox9 which affect Dhh transcription in adrenocortical autografts with or without ACTH stimulation. In ACTHstimulated autografts, Gata4 and Gata6 were downregulated compared to control autografts. This response was linked to rDhh repression. A reporter assay using the upstream region of rDhh and a GATA binding motif revealed that rDhh promoters were significantly upregulated by co-transfection with Gata4 or Gata6 or both. Sry and Sox9 expression in autografts with or without ACTH stimulation were verified by PCR and RNAscope analyses. The ovarian differentiation factors Foxl2 and Rspo1 were also upregulated in the autografts. Gata4 and Gata6 were found to be significant factors in the regulation of rDhh expression and could be associated with adrenocortical autograft maintenance. Gonadal primordia with bipotential testicular and ovarian functions may also be present in these autografts.
GATA4/6 regulate DHH transcription in rat adrenocortical autografts
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Pheochromocytomas arise from the adrenal medulla and are catecholamine-producing tumours. Hereditary pheochromocytoma can be treated with bilateral adrenalectomy and lifelong glucocorticoid replacement therapy 1 . Autotransplantation and allotransplantation of the adrenal cortex are potential alternatives that allow bilateral adrenalectomy patients to avoid adrenal crises 1, 2 . However, adrenal autotransplantation has not been established in humans and its success rate is only 20-35% 3, 4 . Possible reasons for this poor performance include ACTH suppression by negative feedback from excessive postoperative glucocorticoid replacement therapy. This response causes autograft regression. According to previous reports, adrenal autotransplantation has been highly successful in the management of Cushing's disease (ACTH hypersecretion from the pars distalis) [5] [6] [7] . Four patients who underwent bilateral adrenalectomy and ACTH replacement were able to withdraw from glucocorticoid replacement immediately after adrenal autotransplantation 8 . Dexamethasone-induced adrenal atrophy in mice was restored with daily ACTH stimulation 9 . ACTH stimulation after autotransplantation preserves autografts and may involve an unidentified pathway which promotes adrenal cortical regeneration and recovers endocrine function.
In the search for factors affecting post-transplant adrenocortical autograft remodelling and regeneration, we found that Dhh was upregulated and Shh was downregulated in the regeneration step of rat adrenocortical autograft 8 . The HH signalling pathway may participate in adrenocortical autograft regeneration as well as adrenal cortex development. The regulation of Dhh transcription during gonadal development involves transcription factors such as Wt1, Gata4, Gata6, Sox9 and Sry 9, 10 . In this study, we examined whether they affect Dhh transcription in adrenocortical autografts. Although ACTH stimulation is important, to the best of our knowledge, no studies have evaluated the influence of transient ACTH stimulation on adrenal autografts. Therefore, we also assessed the effects of transient ACTH and rDhh transcription-associated factors.
Results and Discussion
ACTH stimulation induced angiogenic factor in adrenal glands. After ACTH stimulation for 2 h, Vegfa showed a 1.8-fold increase in the adrenal gland compared with that in the intact group ( Fig. 1) . Angpt1 in the adrenal gland after ACTH stimulation showed a 0.5-fold decrease compared with that in the intact group ( Fig. 1 ). There was no difference between the intact and saline groups in terms of Vegfa and Angpt1 expression ( Fig. 1 ). Further, no differences in Angpt2 expression among the three groups were observed ( Fig. 1 ). These results corroborated those of previous reports [11] [12] [13] . Even the 2-h ACTH stimulation of the adrenal gland in the present study suggested that ACTH regulates angiogenic factors which could affect adrenal autograft conditions. ACTH suppressed the HH signal in the adrenal autografts. RNAscope analysis in our previous study confirmed that Shh was downregulated and Dhh was upregulated in the autografts 2-3 wks after surgery 10 . Similarly, Shh expression showed a 0.05-fold decrease in the control autografts compared to that in the sham (Fig. 2 ). Dhh expression was 5-fold higher in the autografts than in the sham (Fig. 2 ). In the ACTH-stimulated autograft, neither Shh nor Dhh was upregulated in the adrenocortical autografts relative to the sham. Similar results were observed for Gil1 expression (4.2-fold increase in the control autografts, no difference in the ACTH-stimulated autograft) ( Fig. 2) . Therefore, 2-h ACTH stimulation dysregulated HH signal-related genes in the autografts 2 wks after surgery.
Disp1 encodes HH ligand secretion receptors and is co-localised with the HH ligand in the same cells 14 . Disp1 showed a 2.1-fold upregulation in the control autograft but a 0.6-fold downregulation by ACTH stimulation ( Fig. 2 ). Therefore, both DHH synthesis and release were suppressed in the DHH-producing cells of the ACTH-stimulated autograft. On postoperative day (POD)14, there might be slight HH ligand binding in the autograft HH target cells.
Transcriptional Dhh regulator and effect of ACTH stimulation. The expression of certain Dhh transcriptional regulators may be linked to Dhh expression in the 2-3 wks after surgery, during which time Dhh was upregulated. Therefore, we measured the expression levels of candidate transcription factors in adrenal autografts at POD14.
Wt1 was upregulated in the control-(4.0-fold) and ACTH-stimulated (4.5-fold) adrenal autografts compared with that in the sham adrenal gland ( Fig. 3 ). We were, then, the first to identify Sry and Sox9 expression in adult adrenal cortex using their cDNA in qRT-PCR. Both were elevated in autografts independently of ACTH stimulation (Sry: 4.3-fold change, Sox9: 3.4-fold change) ( Fig. 3 ). Cycle sequence analysis disclosed that these PCR products were indeed Sry and Sox9. RNAscope analysis also confirmed that Sry and Sox9 were localised in the adrenal gland and the autograft. Sry and Sox9 were detected in the zona glomerulosa (ZG) and the estimated undifferentiated zone (ZU), respectively ( Fig. 4A,B ; Supplementary Fig. 1 ). Sry was detected at low levels in the capsule and the zona fasciculate (ZF). In the adrenocortical autograft, Sry was expressed in the stromal cells adjacent to the remnant adrenocortical cells. It was also found in the remnant adrenocortical cells around the capillary circumference at POD14. GATA4 and GATA6 are Shh transcriptional regulators in the limb bud 15 . Gata4 showed a 2.6-fold increase in the autograft (Fig. 3 ). In the ACTH-stimulated autograft, the transcription factors remained upregulated but both Gata4 (0.5-fold change) and Gata6 (0.6-fold change) were inhibited from linking to Dhh compared with that in the control autografts (Gata4: 0.5-fold change, Gata6: 0.6-fold change) ( Fig. 3 ). Therefore, Gata4 and/or Gata6 were considered Dhh regulators in the adrenal autografts. To clarify this hypothesis, a Supplementary Fig. 2 ).
Effect of ACTH on adrenocortical regeneration. Foetal adrenocortical cells are derived from
Gli1-expressing cells 16 . We examined the effects of ACTH on the factors determining adrenal development and steroidogenesis in autografts wherein ACTH repressed Gli1.
In ACTH-stimulated autografts, Nr5a1/Sf1 and Dax1 were not significantly upregulated relative to that in the sham group ( Fig. 6 ). However, ACTH stimulation did not change the level of the stromal markers Nr2f2, Tcf21 and Pdgfra compared with that in the control autografts ( Fig. 6 ). Dhh and Gli1 might be involved in adrenocortical cell differentiation and alter the levels of Nr5a1/Sf1 and Dax1 in adrenocortical autograft cells 8 . In contrast, the capsule cells could be under the control of other regulators such as WT1. Transient ACTH stimulation had a conflicting effect on the regenerations of autograft capsule and adrenocortical cells.
CITED2 co-ordinately controls Nr5a1/Sf1 mRNA accumulation in the adrenogenital primordium (AGP) along with WT1 17 . We found that Cited2 was not upregulated in the autograft (0.4-fold change) ( Fig. 6 ). Therefore, CITED2 might not participate in Nr5a1/Sf1 regulation there. Hoxb9 is an adrenal steroidogenic cell marker in the AGP 18 . In the autograft, Hoxb9 was also downregulated (0.1-fold change) ( Fig. 6 ). For this reason, adrenal steroidogenic-like cells in the AGP might be absent in the autografts at POD14. In other words, Nr5a1/Sf1 found in the autografts at POD14 might be expressed in not newly generated adrenocortical cells, but in survival adrenocortical cells. www.nature.com/scientificreports www.nature.com/scientificreports/ Adrenocortical autograft as a bipotential gonad? Gonads and adrenal glands that originated from an AGP appeared in the form of a coelomic epithelium between the urogenital ridge and the dorsal mesentery. AGP can be detected at embryonic day (E) 9.0 in mice 19 . Adrenal-and gonad anlages progressively individualise from E9.5 to E10.5 and are distinct by E13. Primordial germ cells reach the sexually undetermined gonadal anlage stage by E10. After E11.5-E12, the bipotent gonad differentiates into the testis or ovary with or without Sry and by Sox9 upregulation or downregulation.
We used gonadal marker detection to investigate whether gonadal differentiation occurs in adrenocortical autografts. Normally, rodent Cyp17a1 is suppressed in the adrenal gland by a DNA methylation mechanism but is expressed in the gonad and placenta 20 . Even in the present study, we found no Cyp17a1 expression in the adrenal glands of sham-operated rats. However, the adrenocortical autografts at POD14 presented with relatively upregulated Cyp17a1 (Fig. 7) . Autografts might show changes in their DNA methylation patterns only, but remain adrenal glands with remaining adrenocortical cells, without differentiating to gonadal tissues. We then examined other gonadal markers such as AMHR2 which is specific to AMH target tissues 21 . With or without ACTH stimulation, Amhr2 was upregulated in a 2.6-fold change in adrenal autografts relative to sham rats (Fig. 7) . Amhr2 is expressed in the developing gonads and Mullerian ducts where it mediates AMH-induced regression 22, 23 . In the gonad, AMH signalling promotes masculinisation by suppressing ovary-associated processes such as germ cell meiosis and aromatase and Lhcgr expression 24 . In the present study, Lhcgr showed a 4.8-fold upregulation in the autografts (Fig. 7 ) even though the gonad was intact in the adrenocortical autografted rat, unlike the Lhcgr upregulation found in post-gonadectomy-induced adrenal hyperplasia. Our histological analysis showed no obvious adrenal hyperplasia in the autografts 8 .
FOXL2 is a differentiation factor in the ovary and represses male-specific genes such as Sox9 there 25 . Foxl2 showed a 2.8-fold increase in the present study even though the male determinant factor Sox9 was elevated in the autografts (Fig. 7) . Foxl2 is first detected by the end of the sex determination period 26 . Therefore, undifferentiated gonads occurred in the autografts. The ovarian determiner RSPO1 27 was also upregulated in the autografts (7.1-fold change) ( Fig. 7) . Here, feminisation occurred even in the presence of the male adrenal gland. On the other hand, Vnn1, a marker for steroidogenic Sertoli, Leydig and adrenocortical cells 28, 29 and a protectant against oxidative stress 30 , was downregulated in the autografts (0.4-fold decrease) ( Fig. 7) . Undifferentiated bipotential gonad-like tissues with few or no steroidogenic cells were found in the adrenocortical autograft at POD14. Therefore, gonadal primordia with bipotential testicular and ovarian functions 31 could be present in autografts. 
Conclusion
This report is the first to clearly demonstrate GATA4 and GATA6 were transcription factors in the regulation of Dhh expression in rat adrenocortical autografts. In the present study, only male rats were used and further examinations using female rats are needed to assess the difference of sex. Additionally, transient ACTH stimulation is not considered effective for maintaining the level of Dhh in autografts. Thus, future experiments with the long-term ACTH stimulation for autograft need to be performed.
Methods
Animals. Twenty-six male Wistar rats (age 7 wks, weight 210-270 g) were purchased from Shimizu Laboratory Supplies (Kyoto, Japan) and housed in a sound-attenuated, light-controlled room (12 h light-dark cycle: lights on at 8:00 and off at 20:00; constant 25 ± 1 °C and 50 ± 10% relative humidity) for 2 wks before the operation. Food and water were provided ad libitum. All animal experiments were approved by the Ethics Committee on Animal Experiments at Kansai Medical University (Approval No. 17-051) and conducted in accordance with the Guide for the Care and Use of Laboratory Animals of the Institute for Laboratory Animal Research.
Effects of 2 hours ACTH stimulation on adrenal glands. Four male Wistar rats (age 9 wks, weight
210-240 g) received subcutaneous injections of tetracosactide acetate (ACTH 1-24; 20 μg/200 g BW) dissolved in 0.9% w/v saline (the ACTH group). Four other rats received subcutaneous injections of 0.9% w/v saline (the saline group) between 8:00 and 9:00 were decapitated after 2 h. Four age-sex matched rats were used as the intact group. Between 10:00 and 11:00, their adrenal glands were rapidly excised and stored at −80 °C until RNA isolation.
Adrenocortical autotransplantation. Adrenocortical autotransplantation was performed in twelve 9-wk-old rats as previously described 32 . Briefly, bilateral adrenal glands were resected and divided into four pieces and the medullae were discarded. Adrenocortical autografts were autotransplanted with a pair of fine scissors into two abdominal muscle pockets or the right biceps femoris. Sham operations without adrenalectomy were performed simultaneously. Animals were maintained on saline without any glucocorticoid replacement following the adrenalectomy 33 . ACTH stimulation was performed by injecting tetracosactide acetate (20 μg/200 g BW) dissolved in 0.9% w/v saline 2 h before adrenocortical autotransplantation into abdominal muscle pockets. One rat with ACTH stimulation died within 2 wks after surgery. Two wks after surgery, the adrenal tissues were rapidly excised for gene expression and histological analyses.
Reverse transcription and quantitative (RT-q) PCR.
Total RNA was isolated from each adrenal tissue sample with Sepasol-RNA I Super G reagent (Nacalai Tesque, Kyoto, Japan). Single-strand cDNA was synthesised with a PrimeScript RT reagent kit and gDNA Eraser (TaKaRa Bio Inc., Kyoto, Japan). The mRNA expression levels were determined by quantitative PCR on a Roter-Gene Q platform (Qiagen, Venlo, The Netherlands) using Thunderbird qPCR Mix (Toyobo, Fukui, Japan) and the gene-specific primers listed in Table 1 . To test the amplification efficiencies for primer pairs, a 1:10 dilution was used to create a serial dilution series with the undiluted rat adrenal gland or testis cDNA as a starting point. We calculated the amplification efficiency for each primer pair ( Table 1) . Relative target gene expression levels were evaluated by the 2 −ΔΔCt method 34 using Hprt1 as an internal control according to previous our studies 8, 32 . The 2 −ΔΔCt method assumes that primer amplification efficiencies are similar (usually between 90-110%) among target genes and the internal control. All primers efficiencies except those for Angpt2 and Nr5a1/Sf1 ranged from 90 to 110%. We therefore applied the Pfaffl method 35 , which can account for any differences in efficiency, for Angpt2 and Nr5a1/Sf1 to confirm their reproducibility.
RNAscope. Adrenal glands and autografts were fixed by immersion in 4% formaldehyde with 0.1 M phosphate buffer (pH 7.4) at 4 °C overnight. The tissues were immersed in 30% w/v sucrose solution for cryoprotection. Fixed, frozen tissues were embedded in optimal cutting temperature compound, cut into 10-µm-thick sections and mounted on Superfrost Plus slides (Thermo Fisher Scientific, Waltham, MA, USA). The sections were air-dried at −20 °C and stored at −80 °C until use. When required, they were returned to 20-25 °C, washed once with distilled water and baked at 60 °C for 30 min. In situ hybridisation was conducted using the RNAscope 2. The expression, pCMV6-Entry, rGATA4-pCMV6 and rGATA6-pCMV6 vectors were purchased from Origen (Rockville, MD, USA). Rat Gata4 and Gata6 were subcloned into pCMV6-Entry (rGATA4-pCMV6) and pCMV6-Entry (rGATA6-pCMV6), respectively.
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www.nature.com/scientificreports www.nature.com/scientificreports/ All constructs were confirmed to have no mutation, no insertion, and no deletion by sequencing analysis with a BigDye Terminator Cycle Sequencing Reaction Kit (Applied Biosystems, Foster City, CA, USA) and an ABI PRISM 3100 Genetic Analyzer (Applied Biosystems, Foster City, CA, USA). Both strands were read with sequence primers.
Luciferase reporter assay. H295R cells (human adrenal carcinoma) were grown in DMEM:F12 medium (Thermo Fisher Scientific, Tokyo, Japan) supplemented with 6.25 ng/mL each of insulin, transferrin and selenium, 1.25 mg/mL bovine serum albumin (BSA) and 5.35 ng/mL linoleic acid at 37 °C and 5% CO 2 . The final concentration was adjusted to 2.5% with Nu-Serum I (Corning Inc., Corning, NY, USA).
Cells were seeded in 24-well cell culture plates at a density of 2.5 × 10 5 /well. Two types of luciferase plasmids and one expression vector were co-transfected with Lipofectamine TM 3000 Transfection Reagent (Thermo Fisher Scientific, Tokyo, Japan) according to the manufacturer's protocol. The following amounts of co-transfected plasmids and vectors were placed in each well: 200 ng firefly luciferase-encoding reporter plasmid (pGL4.10), 20 ng Renilla luciferase-encoding internal control plasmid (pGL4.74) and 200 ng expression vectors (pCMV6-Entry, rGata4-pCMV6, or rGata6-pCMV6). Approximately 96 h after transfection, luciferase activity was sequentially measured in duplicate using a PicaGene Dual Sea Pansy Luminescence Kit (TOYO INK CO. Ltd., Chuo-ku, Tokyo, Japan) and the 2030ARVO X multilabel reader (PerkinElmer Japan Co. Ltd., Yokohama, Japan) according to the manufacturer's protocol. Briefly, 20 µL cell lysate per well in passive lysis buffer was transferred to an OptiPlate-96 plate (SUMILON, Tokyo, Japan). Firefly luciferase luminescence (FLU) from the pGL4.10 plasmids and Renilla luciferase luminescence (RLU) from the pGL4.74 plasmid were measured independently. Relative luciferase activity per well was calculated by dividing FLU by RLU. Relative luciferase activity was standardised by the corresponding control conditions, namely, either co-transfection of a pGL4.10 plasmid with a pCMV6-Entry, rGATA4-pCMV6, rGATA6-pCMV6 or rGATA4-pCMV6 with rGATA6-pCMV6 vectors. Activity levels were expressed as the mean of ≥6 independent experiments ± standard error (SE). Normal 
Statistical analysis.

